What's Happening

Immigration
SCOTUS Greenlights Trump's Deportation Push, but Raises Due Process Concerns
What's going on: Yesterday, the Supreme Court cleared the way for the Trump administration to restart deportations of Venezuelan migrants with alleged gang ties. In a 5-4 decision, the Court overturned a lower ruling that temporarily blocked the removals but added a caveat: Detainees must be given due process. That part is already under scrutiny. One man, Kilmar Armando Abrego García, was deported to El Salvador last month without ever seeing a judge — which immigration officials admitted was an “administrative error.” Abrego García, who has protected legal status and no criminal record, is now being held in a notorious mega-prison. His lawyers have denied he has any gang ties, and the Justice Department hasn’t provided any evidence linking him to one. But the administration has signaled they have no plans to bring him back — even as the Supreme Court debates whether they’re required to.
What it means: The Supreme Court’s ruling on Venezuelan migrants is a major win for the Trump administration. Still, migrants will be allowed to present their case to judges in Texas, who will make the final call. As the White House looks to increase the pace of its deportations, Trump has said he’s focused on removing undocumented migrants with criminal records. But proving such allegations can be tricky, and in practice, deportations often happen without sufficient evidence, leaving some individuals vulnerable to persecution. 60 Minutes recently reported that only a small fraction of the 238 Venezuelans deported to El Salvador were actually convicted of any crimes.
Related: The State Department Is Revoking All Visas for South Sudanese Passport Holders (AP News)
Economy
Are Cracks Within the GOP Showing?
What's going on: As Wall Street and global markets continue to experience volatility, President Donald Trump is facing growing pushback on his tariffs — this time from within his own party. Republican lawmakers like Sen. Ted Cruz (R-TX), conservative allies and donors like Elon Musk, and even major Republican influencers like Dave Portnoy and Joe Rogan are questioning Trump’s strategy to reset the global markets and level the tariff playing field. Bill Ackman, the billionaire investor who endorsed Trump in 2024, grimly put it: “We are heading for a self-induced, economic nuclear winter, and we should start hunkering down.” Meanwhile, the New Civil Liberties Alliance (NCLA), a legal nonprofit that’s backed by billionaire Charles Koch, has filed a complaint arguing Trump doesn’t have the power to impose these new tariffs — one of many legal challenges in the works.
What it means: Conservatives’ public rebuke against Trump’s tariffs is showing a fracture within the Republican Party. While some GOP lawmakers have spent the last few days defending the tariffs as necessary, at least a dozen of them have backed legislation aimed at curtailing the president’s ability to impose levies. Trump’s economic policy is even raising concerns that the tariffs could cost the Republican Party in the 2026 midterms, with Sen. Cruz saying the GOP could see a “bloodbath.” In the meantime, the White House says the president is acting within his authority, while one trade advisor told Fox News there’ll be “no recession” (although some CEOs say we’re in one right now). As for Trump: He’s doubling down on his strategy and threatening new 50% tariffs against China.
Related: The Error That Sent the Stock Market Soaring for a Brief Moment (NBC News)
Education
America's Lowest-Scoring Students Are in Freefall. Who's Paying Attention?
What's going on: Once upon a time, America’s lowest-performing students were making real progress. They weren’t catching up to the top scorers, but they were steadily improving on national tests alongside their higher-achieving peers. But since around 2013, these students have been falling even further behind, with sharp declines in math and reading. Researchers blame a tangle of culprits: lingering impacts of the Great Recession, reduced school accountability (especially after “No Child Left Behind” was phased out), and the rise of smartphones, which some studies link to worsening cognitive performance, even in adults. Of course, there’s also the pandemic’s lasting impact on learning, but that’s just one piece of the puzzle. While higher-performing students have started to bounce back post-COVID — the most vulnerable ones are still sliding.
What it means: A US education system that once looked out for lower-performing students is now failing them. Understanding what’s happening with these kids isn’t just about test scores. It’s about the country’s future — economically and politically. The more students struggle, the less prepared they are to thrive in any job, especially technical and high-paying ones, according to education experts. This trend could also hurt the US on the global stage, as other countries are finding ways to support both low- and high-performing students. The situation is also becoming harder to track. Last month, Trump gutted the Department of Education, axing staff behind the only national student test. With less oversight and fewer data points, more struggling kids could fall through the cracks — unseen and unaided.
Related: This Memoir Just Topped the List of Most-Challenged Books (NPR)
Your Political Briefing
The week in political chaos.

Stamp of approval: “He looks like a movie star” — President Donald Trump on the LA Dodgers’ Shohei Ohtani.
On the books: President Donald Trump said the White House is preparing to hold “direct” talks with Iran on Saturday. Trump has previously threatened Iran with military strikes if it doesn’t reach a new nuclear deal with the US.
Speaking out: Second Lady Usha Vance is opening up about what she thinks people don’t understand about her husband in an interview with The Free Press.
Deal or no deal?: Rep. Anna Paulina Luna (R-FL) says House Speaker Mike Johnson (R-LA) has agreed to reinstate vote pairing, which allows lawmakers to cast votes even if they can't be there in person — including for childbirth. But some Democrats are saying not so fast.
Extra Credit

Stream
The end is here: The Handmaid’s Tale’s sixth and final season premieres on Hulu today (the first three episodes are available to stream now). The last installment of the Emmy-winning dystopian drama picks up where season five left off — with June (Elisabeth Moss) coming face-to-face with Serena Joy (Yvonne Strahovski) on a train of Gilead refugees headed to Vancouver. From there, things get...complicated, as June continues her fight to take down Gilead, Luke (O-T Fagbenle) and Moira (Samira Wiley) join the resistance, and Serena joins forces with Commander Lawrence (Bradley Whitford) in a "propulsive final season" that "recaptures the urgency and watchability of its early episodes." Praise be.
For more recs...
Check out the Daily Skimm Weekend newsletter, in your inbox every Saturday and Sunday. We'll help you spend your leisure time well.
IMPORTANT SAFETY INFORMATION
What is the most important information I should know about ZURZUVAE?
ZURZUVAE may cause serious side effects, including:
Decreased ability to drive or do other dangerous activities. ZURZUVAE may decrease your awareness and alertness, which can affect your ability to drive safely or safely do other dangerous activities
Do not drive, operate machinery, or do other dangerous activities until at least 12 hours after taking each dose during your 14-day treatment course of ZURZUVAE
You may not be able to tell on your own if you can drive safely or tell how much ZURZUVAE is affecting you
Decreased awareness and alertness [central nervous system (CNS) depressant effects]. ZURZUVAE may cause sleepiness, drowsiness, slow thinking, dizziness, confusion, and trouble walking
Because of these symptoms, you may be at a higher risk for falls during treatment with ZURZUVAE
Taking alcohol, other medicines that cause CNS depressant effects, or opioids while taking ZURZUVAE can make these symptoms worse and may also cause trouble breathing
Tell your healthcare provider if you develop any of these symptoms, or if they get worse during treatment with ZURZUVAE. Your healthcare provider may decrease your dose or stop ZURZUVAE treatment if you develop these symptoms
ZURZUVAE is a federal controlled substance (C-IV) because it contains zuranolone, which can be abused or lead to dependence. Keep ZURZUVAE in a safe place to protect it from theft. Do not sell or give away ZURZUVAE, because it may harm others and is against the law.
Before taking ZURZUVAE, tell your healthcare provider about all of your medical conditions, including if you:
drink alcohol
have abused or been dependent on prescription medicines, street drugs, or alcohol
have liver or kidney problems
are pregnant or plan to become pregnant. ZURZUVAE may harm your unborn baby
are breastfeeding or plan to breastfeed. ZURZUVAE passes into breast milk, and it is not known if it can harm your baby. Talk to your healthcare provider about the risks and benefits of breastfeeding and about the best way to feed your baby during treatment with ZURZUVAE
Females who are able to become pregnant:
Tell your healthcare provider right away if you become pregnant during treatment with ZURZUVAE.
You should use effective birth control (contraception) during treatment with ZURZUVAE and for 1 week after the final dose
There is a pregnancy registry for females who are exposed to ZURZUVAE during pregnancy. The purpose of the registry is to collect information about the health of females exposed to ZURZUVAE and their baby. If you become pregnant during treatment with ZURZUVAE, talk to your healthcare provider about registering with the National Pregnancy Registry for Antidepressants at 1-844-405-6185 or visit online at https://womensmentalhealth.org/research/pregnancyregistry/antidepressants/
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. ZURZUVAE and some medicines may interact with each other and cause serious side effects. ZURZUVAE may affect the way other medicines work, and other medicines may affect the way ZURZUVAE works.
Especially tell your healthcare provider if you take antidepressants, opioids, or CNS depressants such as benzodiazepines.
What should I avoid while taking ZURZUVAE?
Do not drive a car, operate machinery, or do other dangerous activities until at least 12 hours after taking each dose of ZURZUVAE because ZURZUVAE may make you feel sleepy, confused, or dizzy
Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking ZURZUVAE without talking to your healthcare provider
See “What is the most important information I should know about ZURZUVAE?”
ZURZUVAE may cause serious side effects, including:
See “What is the most important information I should know about ZURZUVAE?”
Increased risk of suicidal thoughts or actions. ZURZUVAE and other antidepressant medicines may increase the risk of suicidal thoughts and actions in people 24 years of age and younger. ZURZUVAE is not for use in children
How can I watch for and try to prevent suicidal thoughts and actions?
Pay close attention to any changes, especially sudden changes in mood, behavior, thoughts, or feelings, or if you develop suicidal thoughts or actions. This is very important when an antidepressant medicine is started or when the dose is changed
Tell your healthcare provider right away if you have any new or sudden changes in mood, behavior, thoughts, or feelings
Keep all follow-up visits with your healthcare provider as scheduled. Call your healthcare provider between visits as needed, especially if you have concerns about symptoms
Tell your healthcare provider right away if you have any of the following symptoms, especially if they are new, worse, or worry you:
attempts to commit suicide
thoughts about suicide or dying
new or worse depression
feeling very agitated or restless
trouble sleeping (insomnia)
new or worse anxiety
panic attacks
new or worse irritability
acting aggressive, being angry, or violent
an extreme increase in activity and talking (mania)
acting on dangerous impulses
other unusual changes in behavior or mood
The most common side effects of ZURZUVAE include:
Sleepiness or drowsiness, dizziness, common cold, diarrhea, feeling tired, weak, or having no energy, and urinary tract infection
These are not all of the possible side effects of ZURZUVAE. Call your doctor for medical advice about side effects. You can report side effects to FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
What is ZURZUVAE® (zuranolone) CIV?
ZURZUVAE is a prescription medicine used to treat adults with postpartum depression (PPD).
It is not known if ZURZUVAE is safe and effective in children.
Please see full Prescribing Information, including Boxed Warning and Medication Guide.
Sponsored by Sage Therapeutics, Inc. and Biogen Inc.
ZUR-US-1093v2 03/25
Live Smarter
Sign up for the Daily Skimm email newsletter. Delivered to your inbox every morning and prepares you for your day in minutes.